Oxford–ZEISS push forward next-generation drug screening technology
The Oxford–ZEISS Centre of Excellence in Biomedical Imaging and ZEISS have entered a proof-of-principle phase to develop a cutting-edge imaging technology capable of precisely measuring how drugs behave within cells and tissues, a breakthrough that could transform drug development. The technology, known as Selective Plane Illumination Lattice Light Sheet Microscopy (SPI LLSM), enables scientists to…
